TITLE

Cholesterol-lowering and Artherosclerosis Inhibitory Effect of Sibu Olive in Cholesterol Fed-rabbit

AUTHOR(S)
Nurulhuda, M. H.; Azlan, Azrina; Ismail, Amin; Amom, Zulkhairi; Shakirin, Faridah Hanim
PUB. DATE
April 2012
SOURCE
Asian Journal of Biochemistry;Apr2012, Vol. 7 Issue 2, p80
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The present study was designed to explore the possible cholesterol lowering effect of Sibu Olive (SO) supplementation on cholesterol level and atherosclerosis inhibitory effect m hypercholesterolemic rabbits. A total of five groups (n = 7); NC (normal diet), PC (normal diet+0.5% cholesterol), HS (hypercholesterolemic diet+10 mg kg day-1 simvastatin), HF (hypercholesterolemic diet+5% fullfat SO) and HD group (hypercholesterolemic diet+5% defatted SO) were established. Body weight and lipid profile analysis [total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C)] were compared to PC. There was rise in body weight changes (1.75-2.24 kg) of the animals. The HD group showed significant reduction in total cholesterol (96.3%) and LDL-C (26.5%) together with increment in HDL-C (46.8%) relative to PC. Furthermore, the atherosclerotic plaque formation in HD group diminished by 79.4% compared to PC. The possible cholesterol lowering effect was contributed by the presence of polyphenols such as phenolic acids, flavonoids, anthocyanidins and anthocyanin of the SO fruit. Hence, these findings are beneficial as it provide alternative means to treat hypercholesterolemia and atherosclerosis.
ACCESSION #
76126528

 

Related Articles

  • Use of rosiglitazone before and after vascular injury in hypercholesterolemic rabbits: Assessment of neointimal formation. Alessi, Alexandre; França Neto, Olímpio Ribeiro; Roberto, Paulo; Brofman, Slud; Prim, Camila; Noronha, Lucia; Kuenzer, Ruy Fernando; Silva, Caetano; Baroncini, Liz Andréa Villela; Précoma, Dalton Bertolim // Thrombosis Journal;2008, Vol. 6, Special section p1 

    Objectives: To analyse the effects of rosiglitazone administered at different times on neointimal formation in hypercholesterolemic rabbits following vascular injury. Methods: Thirty-nine rabbits on a hypercholesterolemic diet were included. The animals underwent balloon catheter injury to the...

  • Effects of rosiglitazone on contralateral iliac artery after vascular injury in hypercholesterolemic rabbits. França Neto, Olímpio Ribeiro; Precoma, Dalton Bertolim; Alessi, Alexandre; Prim, Camila; da Silva, Ruy Fernando Kuenzer Caetano; de Noronha, Lucia; Baroncini, Liz Andréa Villela // Thrombosis Journal;2008, Vol. 6, Special section p1 

    Background: The objective was to evaluate the effects of rosiglitazone on iliac arteries of hypercholesterolemic rabbits undergoing balloon catheter injury in the contralateral iliac arteries. Methods: White male rabbits were fed a hypercholesterolemic diet for 6 weeks and divided into two...

  • Atorvastatin mediates increases in intralesional BAX and BAK expression in human end-stage abdominal aortic aneurysms. Schweitzer, Morris; Mitmaker, Benjamin; Obrand, Daniel; Sheiner, Nathan; Abraham, Cherrie; Dostanic, Stevan; Chalifour, Lorraine E. // Canadian Journal of Physiology & Pharmacology;Nov2009, Vol. 87 Issue 11, p915 

    Chronic apoptosis activation may participate in abdominal aortic aneurysm (AAA) expansion. Statin treatment slows AAA progression independent of cholesterol lowering. We hypothesized that Atorvastatin treatment alters apoptosis protein expression and activation in AAAs. Protein was isolated from...

  • Clinical field-strength MRI of amyloid plaques induced by low-level cholesterol feeding in rabbits. Ronald, John A.; Chen, Yuanxin; Bernas, Lisa; Kitzler, Hagen H.; Rogers, Kem A.; Hegele, Robert A.; Rutt, Brian K. // Brain: A Journal of Neurology;May2009, Vol. 132 Issue 5, p1346 

    Two significant barriers have limited the development of effective treatment of Alzheimers disease. First, for many cases the aetiology is unknown and likely multi-factorial. Among these factors, hypercholesterolemia is a known risk predictor and has been linked to the formation of β-amyloid...

  • Study of cholesterol-lowering effect and safety of simvaglisin on rabbit model of hypercholesterolemia. Yu. Ragino; V. Vavilin; N. Salakhutdinov; S. Makarova; E. Stakhneva; O. Safronova; Yu. Nikitin; G. Tolstikov // Bulletin of Experimental Biology & Medicine;Mar2008, Vol. 145 Issue 3, p317 

    Abstract  Using rabbit model of experimental hypercholesterolemia we showed that the hypocholesterolemic effect of simvaglisin, a complex preparation containing simvastatin and glycyrrhizic acid, in doses corresponding to 40, 66.5, and 100 mg/kg/day simvastatin is equal to the...

  • Clearing Up the Cholesterol Confusion. Sinatra, Stephen // Townsend Letter;Jun2009, Issue 311, p60 

    The article offers a commentary concerning the confusion surrounding the issue on cholesterol. The author puts emphasis on a nonexistent disease called hypercholesteremia. The author also focuses on the standard lipid tests that most physicians recommend patients. Factors to consider if the...

  • Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia not Adequately Controlled with Current Lipid-Lowering Therapy: Design and Rationale of the ODYSSEY FH Studies. Kastelein, John; Robinson, Jennifer; Farnier, Michel; Krempf, Michel; Langslet, Gisle; Lorenzato, Christelle; Gipe, Daniel; Baccara-Dinet, Marie // Cardiovascular Drugs & Therapy;Jun2014, Vol. 28 Issue 3, p281 

    Background: Individuals with heterozygous familial hypercholesterolemia (heFH) have higher levels of low-density lipoprotein cholesterol (LDL-C) and are predisposed to premature cardiovascular disease. Alirocumab is a fully-human, monoclonal antibody targeted to proprotein convertase...

  • Influence of a probiotic soy product on fecal microbiota and its association with cardiovascular risk factors in an animal model.  // Lipids in Health & Disease;2011, Vol. 10 Issue 1, p126 

    The article cites a research study that analyzes the possible association between fecal microbiota, serum lipid parameters and atherosclerotic lesion development in rabbits with induced hypercholesterolemia. It characterized the fecal microbiota and the rabbits were randomly allocated to five...

  • Getting to the feet of the matter. Firth, Niall // Engineer (00137758);11/28/2005, Vol. 293 Issue 7689, p12 

    The article reports that a British researcher has developed a handheld scanner called PADD that could enable early detection of vascular disease which is caused due to blood-flow problems resulting from blocked arteries in the feet. A sensor is placed against the foot to beam infrared light into...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics